Literature DB >> 273132

Extreme leukemic leukocytosis (blast crisis) in childhood.

J C Dearth, K S Fountain, W A Smithson, E O Burgert, G S Gilchrist.   

Abstract

Children with leukemia who have extremely high leukocyte counts (more than 100,000/mm3) when seen initially are at high risk of early sudden death, usually from massive intracerebral hemorrhage. Nine such patients were seen during a 39-month period. Eight had pronounced adenopathy and hepatosplenomegaly without severe anemia or thrombocytopenia. The first six patients died suddenly. Cerebral perivascular infiltration and increased blood viscosity are the probable pathophysiologic mechanisms. A treatment program was developed, the goal being the early elimination of blast cells. Three consecutive patients patients presenting with leukocyte counts greater than 100,000/mm3 were treated with emergency cranial irradiation, and all three survived to receive systemic chemotherapy.

Entities:  

Mesh:

Year:  1978        PMID: 273132

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  Sudden unexpected death from an undiagnosed histiocytic sarcoma in an adolescent female.

Authors:  H R Haynes; Z Melegh; S Vanjani; M Cieka; S Beavers; N Rooney; B Purdue
Journal:  Forensic Sci Med Pathol       Date:  2016-07-27       Impact factor: 2.007

2.  Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.

Authors:  S L Saccente; E C Kohaut; R L Berkow
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

3.  Intracranial bleeding during therapy with L-asparaginase in childhood acute lymphocytic leukemia.

Authors:  C Urban; W D Sager
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

4.  Central nervous system complications of blastic hyperleukocytosis in childhood acute lymphoblastic leukemia: diagnostic and prognostic implications.

Authors:  Mary Kay Koenig; Clark W Sitton; Min Wang; John M Slopis
Journal:  J Child Neurol       Date:  2008-11       Impact factor: 1.987

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.